Study on the Effect of Oral Diammonium Glycyrrhizinate in Attenuating Toxicity and Enhancing Efficacy of CAR-T Cell Therapy
Clinical trial NCT07616271 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07616271
- Sponsor
- Tongji Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-22
- Primary completion
- 2029-05-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.